Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Neck"" wg kryterium: Temat


Tytuł:
Results of salvage neck dissection after chemoradiation in locally advanced head and neck squamous cell carcinoma.
Autorzy:
López L; Department of Otorhinolaryngology, Hospital Universitario Central de Asturias, Avenida de Roma S/N, 33011, Oviedo, Spain.
García-Cabo P; Department of Otorhinolaryngology, Hospital Universitario Central de Asturias, Avenida de Roma S/N, 33011, Oviedo, Spain.
Llorente JL; Department of Otorhinolaryngology, Hospital Universitario Central de Asturias, Avenida de Roma S/N, 33011, Oviedo, Spain.; University of Oviedo, Oviedo, Spain.; Department of Head and Neck Oncology, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.; CIBER de Cáncer, CIBERONC, Madrid, Spain.
López F; Department of Otorhinolaryngology, Hospital Universitario Central de Asturias, Avenida de Roma S/N, 33011, Oviedo, Spain. flopez_.; University of Oviedo, Oviedo, Spain. flopez_.; Department of Head and Neck Oncology, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain. flopez_.; CIBER de Cáncer, CIBERONC, Madrid, Spain. flopez_.
Rodrigo JP; Department of Otorhinolaryngology, Hospital Universitario Central de Asturias, Avenida de Roma S/N, 33011, Oviedo, Spain.; University of Oviedo, Oviedo, Spain.; Department of Head and Neck Oncology, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.; CIBER de Cáncer, CIBERONC, Madrid, Spain.
Pokaż więcej
Źródło:
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery [Eur Arch Otorhinolaryngol] 2024 Feb; Vol. 281 (2), pp. 945-951. Date of Electronic Publication: 2023 Oct 28.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/pathology
Head and Neck Neoplasms*/surgery
Humans ; Squamous Cell Carcinoma of Head and Neck/surgery ; Neck Dissection ; Retrospective Studies ; Salvage Therapy ; Neoplasm Recurrence, Local/pathology
Czasopismo naukowe
Tytuł:
Anatomic Variability of the Accessory Nerve: Implications for Dissection of Level IIB.
Autorzy:
Pagedar NA; Department of Otolaryngology - Head and Neck Surgery, University of Iowa, Iowa City, Iowa, U.S.A.
Hoffman HT; Department of Otolaryngology - Head and Neck Surgery, University of Iowa, Iowa City, Iowa, U.S.A.
Pokaż więcej
Źródło:
The Laryngoscope [Laryngoscope] 2024 Jan; Vol. 134 (1), pp. 154-159. Date of Electronic Publication: 2023 Jun 08.
Typ publikacji:
Journal Article
MeSH Terms:
Accessory Nerve*
Head and Neck Neoplasms*
Humans ; Neck Dissection/methods ; Neck ; Lymph Node Excision
Czasopismo naukowe
Tytuł:
Neck scar perception after neck dissection in HPV-associated oropharyngeal squamous cell carcinoma.
Autorzy:
Au VH; Department of Otolaryngology - Head and Neck Surgery, Massachusetts Eye and Ear, Boston, MA, United States of America; Department of Otolaryngology - Head and Neck Surgery, Harvard Medical School, Boston, MA, United States of America.
Miller LE; Department of Otolaryngology - Head and Neck Surgery, Massachusetts Eye and Ear, Boston, MA, United States of America; Department of Otolaryngology - Head and Neck Surgery, Harvard Medical School, Boston, MA, United States of America.
Mitchell MB; Department of Otolaryngology - Head and Neck Surgery, Massachusetts Eye and Ear, Boston, MA, United States of America; Department of Otolaryngology - Head and Neck Surgery, Harvard Medical School, Boston, MA, United States of America.
Larson AR; Department of Otolaryngology - Head and Neck Surgery, Massachusetts Eye and Ear, Boston, MA, United States of America; Department of Otolaryngology - Head and Neck Surgery, Harvard Medical School, Boston, MA, United States of America.
Lin DT; Department of Otolaryngology - Head and Neck Surgery, Massachusetts Eye and Ear, Boston, MA, United States of America; Department of Otolaryngology - Head and Neck Surgery, Harvard Medical School, Boston, MA, United States of America.
Feng AL; Department of Otolaryngology - Head and Neck Surgery, Massachusetts Eye and Ear, Boston, MA, United States of America; Department of Otolaryngology - Head and Neck Surgery, Harvard Medical School, Boston, MA, United States of America.
Richmon JD; Department of Otolaryngology - Head and Neck Surgery, Massachusetts Eye and Ear, Boston, MA, United States of America; Department of Otolaryngology - Head and Neck Surgery, Harvard Medical School, Boston, MA, United States of America. Electronic address: Jeremy_.
Pokaż więcej
Źródło:
American journal of otolaryngology [Am J Otolaryngol] 2024 Jan-Feb; Vol. 45 (1), pp. 104074. Date of Electronic Publication: 2023 Oct 12.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/pathology
Papillomavirus Infections*/complications
Papillomavirus Infections*/surgery
Oropharyngeal Neoplasms*/pathology
Head and Neck Neoplasms*/surgery
Robotic Surgical Procedures*/adverse effects
Humans ; Squamous Cell Carcinoma of Head and Neck/surgery ; Squamous Cell Carcinoma of Head and Neck/etiology ; Neck Dissection/adverse effects ; Quality of Life ; Cicatrix/etiology ; Retrospective Studies ; Case-Control Studies ; Perception
Czasopismo naukowe
Tytuł:
Role of primary tumor volume and metastatic lymph node volume in response to curative effect of definitive radiotherapy for locally advanced head and neck cancer.
Autorzy:
Mao W; Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, 400016, China.; Department of Oncology, Chongqing University Three Gorges Hospital, Chongqing, China.
Zhang T; Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, 400016, China.
Li L; Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, 400016, China.
Peng S; Department of Sociology, Indiana University, Bloomington, IN, USA.
Gong H; Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, 400016, China.
Li M; Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, 400016, China. .
Pokaż więcej
Źródło:
European journal of medical research [Eur J Med Res] 2024 Feb 04; Vol. 29 (1), pp. 98. Date of Electronic Publication: 2024 Feb 04.
Typ publikacji:
Journal Article
MeSH Terms:
Head and Neck Neoplasms*/radiotherapy
Head and Neck Neoplasms*/pathology
Humans ; Tumor Burden ; Squamous Cell Carcinoma of Head and Neck/radiotherapy ; Squamous Cell Carcinoma of Head and Neck/pathology ; Lymph Nodes/pathology ; Chemoradiotherapy ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Tumor mutational burden predictability in head and neck squamous cell carcinoma patients treated with immunotherapy: systematic review and meta-analysis.
Autorzy:
Rodrigo JP; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias, University of Oviedo, 33011, Oviedo, Spain.; Ciber de Cáncer, CIBERONC, 28029, Madrid, Spain.
Sánchez-Canteli M; Ciber de Cáncer, CIBERONC, 28029, Madrid, Spain. .; Department of Otolaryngology, Hospital Universitario de Cabueñes and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011, Oviedo, Spain. .
Otero-Rosales M; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias, University of Oviedo, 33011, Oviedo, Spain.; Ciber de Cáncer, CIBERONC, 28029, Madrid, Spain.
Martínez-Camblor P; Department of Anesthesiology, Dartmouth Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.; Faculty of Health Sciences, Universidad Autonoma de Chile, 7500912, Providencia, Chile.
Hermida-Prado F; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias, University of Oviedo, 33011, Oviedo, Spain.; Ciber de Cáncer, CIBERONC, 28029, Madrid, Spain.
García-Pedrero JM; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias, University of Oviedo, 33011, Oviedo, Spain.; Ciber de Cáncer, CIBERONC, 28029, Madrid, Spain.
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2024 Feb 04; Vol. 22 (1), pp. 135. Date of Electronic Publication: 2024 Feb 04.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Immunotherapy*/methods
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/genetics
Humans ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/genetics ; Prognosis ; Survival Analysis ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/analysis ; Mutation/genetics
Czasopismo naukowe
Tytuł:
Evolutionary dynamics of tipifarnib in HRAS mutated head and neck squamous cell carcinoma.
Autorzy:
Jagadeeshan S; The Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, Israel; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Suryamohan K; BostonGene Corporation, Waltham, MA, USA.
Shin N; BostonGene Corporation, Waltham, MA, USA.
Mathukkada S; The Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, Israel; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Boyko A; BostonGene Corporation, Waltham, MA, USA.
Melikhova D; BostonGene Corporation, Waltham, MA, USA.
Tsareva A; BostonGene Corporation, Waltham, MA, USA.
Yunusova L; BostonGene Corporation, Waltham, MA, USA.
Pravdivtseva E; BostonGene Corporation, Waltham, MA, USA.
Stupichev D; BostonGene Corporation, Waltham, MA, USA.
Shaposhnikov K; BostonGene Corporation, Waltham, MA, USA.
Peterson A; BostonGene Corporation, Waltham, MA, USA.
Bednyagin L; BostonGene Corporation, Waltham, MA, USA.
Shugaev-Mendosa E; BostonGene Corporation, Waltham, MA, USA.
Kessler L; Kura Oncology, Inc., San Diego, CA, USA.
Burrows F; Kura Oncology, Inc., San Diego, CA, USA.
Ho AL; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York City, NY, USA.
Agrawal N; Department of Surgery, Section of Otolaryngology-Head and Neck Surgery, University of Chicago, IL, USA.
Pearson AT; Department of Medicine, Section of Hematology and Oncology, University of Chicago, Chicago, IL, USA.
Izumchenko E; Department of Medicine, Section of Hematology and Oncology, University of Chicago, Chicago, IL, USA.
Cole G; Department of Pathology, University of Chicago, Chicago, IL, USA.
Elkabets M; The Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, Israel; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel. Electronic address: .
Rosenberg AJ; Department of Medicine, Section of Hematology and Oncology, University of Chicago, Chicago, IL, USA. Electronic address: .
Pokaż więcej
Źródło:
Oral oncology [Oral Oncol] 2024 Feb; Vol. 149, pp. 106688. Date of Electronic Publication: 2024 Jan 13.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Proto-Oncogene Proteins c-akt*/metabolism
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/genetics
Quinolones*
Female ; Humans ; Middle Aged ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/genetics ; Phosphatidylinositol 3-Kinases/genetics ; Phosphatidylinositol 3-Kinases/metabolism ; Neoplasm Recurrence, Local/drug therapy ; Cell Line, Tumor ; Tumor Microenvironment ; Proto-Oncogene Proteins p21(ras)/genetics
Czasopismo naukowe
Tytuł:
Sentinel lymph node biopsy versus elective neck dissection in management of the clinically negative (cN0) neck in patients with oral squamous cell carcinoma: A systematic review and meta-analysis.
Autorzy:
Al-Moraissi EA; Department of Oral and Maxillofacial Surgery, Thamar University, Yemen. Electronic address: .
Marwan H; University of Texas Medical Branch at Galveston, USA; King Abdulaiz University, Jeddah, Saudi Arabia. Electronic address: .
Elayah SA; Department of Oral and Maxillofacial Surgery, Jiblah University For Medical and Health Sciences, Ibb, Yemen.
Traxler-Weidenauer D; Department of Oral and Maxillofacial Surgery, Medical University of Vienna, Vienna, Austria.
Paraskevopoulos K; Oral and Maxillofacial Surgery Department, Papanikolaou Hospital, Thessaloniki, Greece.
Amir Rais M; Mayo Clinic OMFS researcher, Minnesota, USA.
Zimmermann M; Department of Oral and Maxillofacial Surgery, Medical University of Vienna, Vienna, Austria.
Pokaż więcej
Źródło:
Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery [J Craniomaxillofac Surg] 2024 Feb; Vol. 52 (2), pp. 141-150. Date of Electronic Publication: 2024 Jan 03.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Carcinoma, Squamous Cell*/pathology
Mouth Neoplasms*/pathology
Head and Neck Neoplasms*/surgery
Head and Neck Neoplasms*/pathology
Humans ; Neck Dissection/methods ; Sentinel Lymph Node Biopsy/methods ; Squamous Cell Carcinoma of Head and Neck/surgery ; Squamous Cell Carcinoma of Head and Neck/pathology ; Neoplasm Staging
Czasopismo naukowe
Tytuł:
A novel pipeline for prioritizing cancer type-specific therapeutic vulnerabilities using DepMap identifies PAK2 as a target in head and neck squamous cell carcinomas.
Autorzy:
Sannigrahi MK; Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA, USA.
Cao AC; Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA, USA.
Rajagopalan P; Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA, USA.
Sun L; Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Brody RM; Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA, USA.
Raghav L; Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA, USA.
Gimotty PA; Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA, USA.
Basu D; Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA, USA.; Ellen and Ronald Caplan Cancer Center, The Wistar Institute, Philadelphia, PA, USA.
Pokaż więcej
Źródło:
Molecular oncology [Mol Oncol] 2024 Feb; Vol. 18 (2), pp. 336-349. Date of Electronic Publication: 2023 Dec 13.
Typ publikacji:
Journal Article
MeSH Terms:
Protein Serine-Threonine Kinases*
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/genetics
Humans ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/genetics ; Cell Line, Tumor ; p21-Activated Kinases/genetics
Czasopismo naukowe
Tytuł:
Carboplatin and paclitaxel after anti-PD-1 or anti-PD-L1 antibody therapy in recurrent and/or metastatic squamous cell carcinoma of head and neck.
Autorzy:
Humphries A; Virginia Tech Carilion School of Medicine, Roanoke, Virginia, USA.
Zhou CJ; School of Medicine, University of California San Francisco, San Francisco, California, USA.
Welsh M; Stanford Cancer Institute, Palo Alto, California, USA.
Lem M; Department of Plastic and Reconstructive Surgery, University of California San Francisco, San Francisco, California, USA.
Kang H; Department of Medicine, University of California San Francisco, San Francisco, California, USA.
Algazi AP; Department of Medicine, University of California San Francisco, San Francisco, California, USA.
Pokaż więcej
Źródło:
Head & neck [Head Neck] 2024 Feb; Vol. 46 (2), pp. 321-327. Date of Electronic Publication: 2023 Nov 23.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/drug therapy
Carcinoma, Squamous Cell*/etiology
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/etiology
Humans ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/etiology ; Carboplatin ; Paclitaxel ; B7-H1 Antigen ; Retrospective Studies ; Neoplasm Recurrence, Local/pathology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Czasopismo naukowe
Tytuł:
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab.
Autorzy:
Serafini MS; Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Cavalieri S; Head and Neck Medical Oncology, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy.; Department of Oncology and Hemato-oncology, University of Milan, Milano, Italy.
Licitra L; Head and Neck Medical Oncology, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy.; Department of Oncology and Hemato-oncology, University of Milan, Milano, Italy.
Pistore F; Head and Neck Medical Oncology, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy.
Lenoci D; Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Canevari S; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Airoldi M; Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.
Cossu Rocca M; European Institute of Oncology, Milano, Italy.
Strojan P; University of Ljubljana, Ljubljana, Slovenia.
Kuhar CG; University of Ljubljana, Ljubljana, Slovenia.; Institute of Oncology, Ljubljana, Slovenia.
Merlano M; Candiolo Cancer Institute, Candiolo, Italy.
Perrone F; Department of Diagnostic Pathology and Laboratory, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Vingiani A; Department of Oncology and Hemato-oncology, University of Milan, Milano, Italy.; Department of Diagnostic Pathology and Laboratory, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Denaro N; Medical Oncology, ARCO Foundation, Cuneo, Italy.
Perri F; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
Argiris A; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Gurizzan C; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.
Ghi MG; Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy.
Cassano A; Policlinico Universitario Agostino Gemelli Dipartimento di scienze mediche e chirurgiche, Roma, Italy.
Allegrini G; Azienda USL Toscana nord ovest Sede di Livorno, Pisa, Italy.
Bossi P; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.
De Cecco L; Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy .
Pokaż więcej
Źródło:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Jan 30; Vol. 12 (1). Date of Electronic Publication: 2024 Jan 30.
Typ publikacji:
Multicenter Study; Clinical Trial, Phase III; Journal Article
MeSH Terms:
Nivolumab*/therapeutic use
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/genetics
Humans ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/genetics ; Platinum ; Biomarkers
Czasopismo naukowe
Tytuł:
Mononuclear phagocyte system-related multi-omics features yield head and neck squamous cell carcinoma subtypes with distinct overall survival, drug, and immunotherapy responses.
Autorzy:
Zhang C; Department of Epidemiology and Health Statistics, School of Public Health, Chongqing Medical University, Yixue Road, Chongqing, 400016, China.
Deng J; Department of Epidemiology and Health Statistics, School of Public Health, Chongqing Medical University, Yixue Road, Chongqing, 400016, China.
Li K; Department of Epidemiology and Health Statistics, School of Public Health, Chongqing Medical University, Yixue Road, Chongqing, 400016, China.
Lai G; Department of Epidemiology and Health Statistics, School of Public Health, Chongqing Medical University, Yixue Road, Chongqing, 400016, China.
Liu H; Department of Epidemiology and Health Statistics, School of Public Health, Chongqing Medical University, Yixue Road, Chongqing, 400016, China.
Zhang Y; Department of Epidemiology and Health Statistics, School of Public Health, Chongqing Medical University, Yixue Road, Chongqing, 400016, China.
Xie B; Department of Epidemiology and Health Statistics, School of Public Health, Chongqing Medical University, Yixue Road, Chongqing, 400016, China. .
Zhong X; Department of Epidemiology and Health Statistics, School of Public Health, Chongqing Medical University, Yixue Road, Chongqing, 400016, China. .
Pokaż więcej
Źródło:
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Jan 27; Vol. 150 (2), pp. 37. Date of Electronic Publication: 2024 Jan 27.
Typ publikacji:
Journal Article
MeSH Terms:
Multiomics*
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/genetics
Humans ; Squamous Cell Carcinoma of Head and Neck/genetics ; Squamous Cell Carcinoma of Head and Neck/therapy ; Mononuclear Phagocyte System ; Immunotherapy ; Prognosis ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Occult metastasis is no burden factor in oral squamous cell carcinoma patients when adhering to a standardized approach in neck dissection.
Autorzy:
Struckmeier AK; Department of Oral and Cranio-Maxillofacial Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Glückstraße 11, 91054, Erlangen, Germany. .; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen, Germany. .
Buchbender M; Department of Oral and Cranio-Maxillofacial Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Glückstraße 11, 91054, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen, Germany.
Moest T; Department of Oral and Cranio-Maxillofacial Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Glückstraße 11, 91054, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen, Germany.
Lutz R; Department of Oral and Cranio-Maxillofacial Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Glückstraße 11, 91054, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen, Germany.
Agaimy A; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen, Germany.; Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Kesting M; Department of Oral and Cranio-Maxillofacial Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Glückstraße 11, 91054, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen, Germany.
Pokaż więcej
Źródło:
Clinical oral investigations [Clin Oral Investig] 2024 Jan 24; Vol. 28 (1), pp. 113. Date of Electronic Publication: 2024 Jan 24.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/surgery
Mouth Neoplasms*/surgery
Head and Neck Neoplasms*
Metrizamide/*analogs & derivatives
Male ; Humans ; Squamous Cell Carcinoma of Head and Neck ; Neck Dissection ; Retrospective Studies ; Lymphatic Metastasis
Czasopismo naukowe
Tytuł:
An ESR1-Related Gene Signature Identifies Head and Neck Squamous Cell Carcinoma with Imputed Susceptibility to Endocrine Therapy.
Autorzy:
Almouhanna F; Department of Otorhinolaryngology, Head and Neck Surgery, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Hess J; Department of Otorhinolaryngology, Head and Neck Surgery, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Research Group Molecular Mechanisms of Head and Neck Tumors, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 19; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 19.
Typ publikacji:
Journal Article
MeSH Terms:
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/genetics
Humans ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/genetics ; Quality of Life
Czasopismo naukowe
Tytuł:
MTDH enhances radiosensitivity of head and neck squamous cell carcinoma by promoting ferroptosis based on a prognostic signature.
Autorzy:
Cao X; The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu 210009, China.
Ge Y; The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu 210009, China.
Yan Z; The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu 210009, China.
Hu X; The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu 210009, China.
Peng F; The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu 210009, China.
Zhang Y; The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu 210009, China.
He X; The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu 210009, China.; The Fourth School of Clinical Medicine, Nanjing Medical University, 101 Longmian Avenue, Jiangning District, Nanjing, Jiangsu 210000, China.; Xuzhou Medical University, No. 209, Tongshan Road, Xuzhou, Jiangsu 221000, China.
Zong D; The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu 210009, China.
Pokaż więcej
Źródło:
Journal of radiation research [J Radiat Res] 2024 Jan 19; Vol. 65 (1), pp. 10-27.
Typ publikacji:
Journal Article
MeSH Terms:
Ferroptosis*/genetics
Head and Neck Neoplasms*/genetics
Head and Neck Neoplasms*/radiotherapy
Humans ; Prognosis ; Squamous Cell Carcinoma of Head and Neck/genetics ; Squamous Cell Carcinoma of Head and Neck/radiotherapy ; Transcription Factors ; Radiation Tolerance/genetics ; Tumor Microenvironment ; Membrane Proteins/genetics ; RNA-Binding Proteins
Czasopismo naukowe
Tytuł:
Femoral neck system versus multiple cannulated screws for the fixation of Pauwels classification type II femoral neck fractures in older female patients with low bone mass.
Autorzy:
Yeoh SC; School of Medicine, Tzu Chi University, Hualien, Taiwan.
Wu WT; School of Medicine, Tzu Chi University, Hualien, Taiwan.; Department of Orthopedics, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, 970473, Taiwan.
Peng CH; School of Medicine, Tzu Chi University, Hualien, Taiwan.; Department of Orthopedics, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, 970473, Taiwan.
Yao TK; School of Medicine, Tzu Chi University, Hualien, Taiwan.; Department of Orthopedics, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, 970473, Taiwan.
Chang CM; Department of Orthopedics, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, 970473, Taiwan.
Liu KL; School of Medicine, Tzu Chi University, Hualien, Taiwan.; Department of Orthopedics, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, 970473, Taiwan.
Yu TC; School of Medicine, Tzu Chi University, Hualien, Taiwan.; Department of Orthopedics, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, 970473, Taiwan.
Chen IH; School of Medicine, Tzu Chi University, Hualien, Taiwan.; Department of Orthopedics, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, 970473, Taiwan.
Wang JH; Department of Medical Research, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.
Yeh KT; School of Medicine, Tzu Chi University, Hualien, Taiwan. .; Department of Orthopedics, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, 970473, Taiwan. .; Department of Medical Education, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan. .; Graduate Institute of Clinical Pharmacy, Tzu Chi University, Hualien, Taiwan. .
Pokaż więcej
Źródło:
BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2024 Jan 13; Vol. 25 (1), pp. 62. Date of Electronic Publication: 2024 Jan 13.
Typ publikacji:
Journal Article
MeSH Terms:
Femoral Neck Fractures*/surgery
Femoral Neck Fractures*/etiology
Femur Head Necrosis*/etiology
Humans ; Female ; Aged ; Middle Aged ; Aged, 80 and over ; Femur Neck ; Blood Loss, Surgical ; Fracture Fixation, Internal/adverse effects ; Fracture Fixation, Internal/methods ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Application of robot navigation system for insertion of femoral neck system in the treatment of femoral neck fracture.
Autorzy:
Liu G; Department of Trauma Center, Liuzhou Worker's Hospital, The Fourth Affiliated Hospital of Guangxi Medical University, Guangxi, 545005, China.
Yang C; Department of Trauma Center, Liuzhou Worker's Hospital, The Fourth Affiliated Hospital of Guangxi Medical University, Guangxi, 545005, China.
Wang R; Department of Trauma Center, Liuzhou Worker's Hospital, The Fourth Affiliated Hospital of Guangxi Medical University, Guangxi, 545005, China.
Tang J; Department of Trauma Center, Liuzhou Worker's Hospital, The Fourth Affiliated Hospital of Guangxi Medical University, Guangxi, 545005, China.
Wu H; Department of Trauma Center, Liuzhou Worker's Hospital, The Fourth Affiliated Hospital of Guangxi Medical University, Guangxi, 545005, China.
Wei L; Department of Trauma Center, Liuzhou Worker's Hospital, The Fourth Affiliated Hospital of Guangxi Medical University, Guangxi, 545005, China.
Hu J; Department of Trauma Center, Liuzhou Worker's Hospital, The Fourth Affiliated Hospital of Guangxi Medical University, Guangxi, 545005, China. .
Pokaż więcej
Źródło:
BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2024 Jan 10; Vol. 25 (1), pp. 47. Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:
Journal Article
MeSH Terms:
Robotics*
Femoral Neck Fractures*/diagnostic imaging
Femoral Neck Fractures*/surgery
Fenofibrate*
Surgical Wound*
Humans ; Femur Neck ; Blood Loss, Surgical ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Do patients with cN0 oral squamous cell carcinoma benefit from elective neck dissection? A large-scale population-based study.
Autorzy:
Wu Q; Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Stomatological Hospital of Chongqing Medical University, No. 426 Songshi North Road, Yubei District, Chongqing, China.; Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Stomatological Hospital of Chongqing Medical University, Chongqing, China.
Xia Y; Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Stomatological Hospital of Chongqing Medical University, No. 426 Songshi North Road, Yubei District, Chongqing, China.; Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Stomatological Hospital of Chongqing Medical University, Chongqing, China.
Qiu L; Department of Oral and Maxillofacial Surgery, Sun Yat-Sen Memorial Hospital, Guangzhou, China.
Wen S; Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Stomatological Hospital of Chongqing Medical University, No. 426 Songshi North Road, Yubei District, Chongqing, China.; Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Stomatological Hospital of Chongqing Medical University, Chongqing, China.
Li Q; Department of Oral and Maxillofacial Surgery, Sun Yat-Sen Memorial Hospital, Guangzhou, China.
Gao X; Department of Oral and Maxillofacial Surgery, Stomatological Hospital of Chongqing Medical University, Chongqing, China.
Jiang W; Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Stomatological Hospital of Chongqing Medical University, No. 426 Songshi North Road, Yubei District, Chongqing, China.; Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Stomatological Hospital of Chongqing Medical University, Chongqing, China.
Wang T; Department of Oral and Maxillofacial Surgery, Stomatological Hospital of Chongqing Medical University, Chongqing, China.
Ji P; Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Stomatological Hospital of Chongqing Medical University, No. 426 Songshi North Road, Yubei District, Chongqing, China. .; Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Stomatological Hospital of Chongqing Medical University, Chongqing, China. .
Ou Z; Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Stomatological Hospital of Chongqing Medical University, No. 426 Songshi North Road, Yubei District, Chongqing, China. .; Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Stomatological Hospital of Chongqing Medical University, Chongqing, China. .
Pokaż więcej
Źródło:
BMC oral health [BMC Oral Health] 2024 Jan 06; Vol. 24 (1), pp. 32. Date of Electronic Publication: 2024 Jan 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Squamous Cell*/surgery
Mouth Neoplasms*/surgery
Tongue Neoplasms*
Head and Neck Neoplasms*
Humans ; Squamous Cell Carcinoma of Head and Neck ; Neck Dissection ; Cohort Studies ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Utility of palliative prognostic index and neutrophil-to-lymphocyte ratio in predicting prognosis of end-stage squamous cell carcinoma of head and neck.
Autorzy:
Higashino M; Department of Otorhinolaryngology - Head and Neck Surgery, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Sugimoto K; School of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Onishi S; School of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Okabe K; School of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Yasuda C; Broad-Based Network Medical Center, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Tadokoro H; Broad-Based Network Medical Center, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Kawata R; Department of Otorhinolaryngology - Head and Neck Surgery, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Pokaż więcej
Źródło:
Head & neck [Head Neck] 2024 Jan; Vol. 46 (1), pp. 23-28. Date of Electronic Publication: 2023 Oct 18.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/pathology
Head and Neck Neoplasms*/therapy
Head and Neck Neoplasms*/pathology
Humans ; Squamous Cell Carcinoma of Head and Neck/therapy ; Squamous Cell Carcinoma of Head and Neck/pathology ; Neutrophils/pathology ; Prognosis ; Lymphocyte Count ; Lymphocytes/pathology ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Somatostatin receptor2 (SSTR2) expression, prognostic implications, modifications and potential therapeutic strategies associates with head and neck squamous cell carcinomas.
Autorzy:
Fan S; Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China; Hunan Clinical Medical Research Center for Cancer Pathogenic Genes Testing and Diagnosis, Changsha, Hunan 410011, China.
Zheng H; Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China; Hunan Clinical Medical Research Center for Cancer Pathogenic Genes Testing and Diagnosis, Changsha, Hunan 410011, China.
Zhan Y; Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China; Hunan Clinical Medical Research Center for Cancer Pathogenic Genes Testing and Diagnosis, Changsha, Hunan 410011, China.
Luo J; Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China; Hunan Clinical Medical Research Center for Cancer Pathogenic Genes Testing and Diagnosis, Changsha, Hunan 410011, China.
Zang H; Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China; Hunan Clinical Medical Research Center for Cancer Pathogenic Genes Testing and Diagnosis, Changsha, Hunan 410011, China.
Wang H; Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China; Hunan Clinical Medical Research Center for Cancer Pathogenic Genes Testing and Diagnosis, Changsha, Hunan 410011, China.
Wang W; Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Xu Y; Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China; Hunan Clinical Medical Research Center for Cancer Pathogenic Genes Testing and Diagnosis, Changsha, Hunan 410011, China. Electronic address: .
Pokaż więcej
Źródło:
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2024 Jan; Vol. 193, pp. 104223. Date of Electronic Publication: 2023 Nov 29.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Head and Neck Neoplasms*/diagnosis
Head and Neck Neoplasms*/genetics
Head and Neck Neoplasms*/therapy
Carcinoma, Squamous Cell*/diagnosis
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/therapy
Humans ; Squamous Cell Carcinoma of Head and Neck/diagnosis ; Squamous Cell Carcinoma of Head and Neck/genetics ; Squamous Cell Carcinoma of Head and Neck/therapy ; Prognosis ; Biomarkers, Tumor/genetics ; Somatostatin
Czasopismo naukowe
Tytuł:
Correlation between preoperative peripheral blood NLR, PLR, LMR and prognosis of patients with head and neck squamous cell carcinoma.
Autorzy:
Zhou J; Department of Otolaryngology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, China.
Wei S; Department of General Surgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230000, China.
Guo X; Department of Neurosurgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, China.
Huang Y; Department of Otolaryngology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, China.
Zhang Y; Department of Otolaryngology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, China.
Hong Y; Department of Otolaryngology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, China.
Chen X; Department of Otolaryngology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, China.
Lu M; Department of Otolaryngology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, China.
Zheng F; Department of Neurosurgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, China. .
Zheng C; Department of Otolaryngology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Dec 18; Vol. 23 (1), pp. 1247. Date of Electronic Publication: 2023 Dec 18.
Typ publikacji:
Journal Article
MeSH Terms:
Neutrophils*
Head and Neck Neoplasms*/surgery
Head and Neck Neoplasms*/pathology
Humans ; Squamous Cell Carcinoma of Head and Neck/surgery ; Squamous Cell Carcinoma of Head and Neck/pathology ; Monocytes/pathology ; Retrospective Studies ; Lymphocytes/pathology ; Prognosis ; Postoperative Complications/pathology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies